Ransomware Attack Hits Clinical Trial Software Vendor
Marianne Kolbasuk McGee
A recent ransomware attack on a provider of software used by firms involved with COVID-19 vaccine development and other drug clinical trials illustrates the increasing cyberthreats facing medical industry supply chain partners.
Philadelphia-based eResearchTechnology, which provides clinical trial oversight software to drug makers and testing firms, was recently hit by a variant of the Ryuk ransomware, the company confirmed to Information Security Media Group on Tuesday.
"On Sept. 20, ERT discovered a ransomware cyberattack," ERT vice president of marketing strategy Drew Bustos tells ISMG. "As a precautionary measure, we took...